Infliximab for pediatric patients with ulcerative colitis: a phase 3, open-label, uncontrolled, multicenter trial in Japan

BACKGROUND: Pediatric ulcerative colitis (UC) is typically more extensive and has a more active disease course than adult UC, and requires early treatment augmentation to achieve and maintain disease remission. The present study aimed to investigate the efficacy, safety, and pharmacokinetic profile...

Descripción completa

Detalles Bibliográficos
Autores principales: Tajiri, Hitoshi, Arai, Katsuhiro, Kagimoto, Seiichi, Kunisaki, Reiko, Hida, Nobuyuki, Sato, Noriko, Yamada, Hiroshi, Nagano, Mieko, Susuta, Yutaka, Ozaki, Kunihiko, Kondo, Kazuoki, Hibi, Toshifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790239/
https://www.ncbi.nlm.nih.gov/pubmed/31607268
http://dx.doi.org/10.1186/s12887-019-1739-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790239/
https://www.ncbi.nlm.nih.gov/pubmed/31607268
http://dx.doi.org/10.1186/s12887-019-1739-5

Ejemplares similares